
CATrends: Deceptive Influencer Marketing
It’s a hot sponcon summer.
Fust et al. v. Gilead Sciences, Inc.
23-at-1244, E.D. Cal.
(Sept. 2023)
Remdesivir
Falsely marketing Remdesivir as safe and effective against COVID-19 without disclosing its limitations and adverse events, including fatalities
Pending
It’s a hot sponcon summer.
What’s this reservation good for?
TINA.org continues to support FTC, New York in federal court.
A bogus connection to major retailers is just the beginning.
Don’t pay for free online government forms.